Single Best Answers and EMQs in Clinical Pathology by Sukhpreet Dubb
Overview: Single Best Answer (SBA) and Extended Matching Question (EMQ) examinations are increasingly popular means of testing medical students and those undertaking postgraduate qualifications in a number of subject areas.
Written by a final year medical student, junior doctors and an experienced clinician, Single Best Answers and EMQs in Clinical Pathology provides invaluable guidance from authors who understand from personal experience that detailed and accurate explanations are the key to successful revision.
This book presents 200 SBA-style and 50 EMQ-style questions arranged by sub-specialty area as well as a practice exam of random questions. A clear discussion of how the correct answer was reached and other options ruled out for every question is given at the end of each section, making this book an excellent learning aid during all stages of undergraduate clinical studies and beyond into postgraduate training, and particularly while preparing for medical finals.
Schizophrenia (Oxford Psychiatry Library) by David Castle & Peter Buckley
Overview: Part of the Oxford Psychiatry Library of pocketbooks, this user-friendly and practical guide will outline the diagnosis, evaluation and treatment of patients with schizophrenia. Co-authored by two global experts on the management of patients with psychosis, this pocketbook will serve as a useful guide for psychiatrists, trainees, psychiatric specialist nurses, and interested general practitioners.
Schizophrenia is one of the most disabling mental illnesses and is also highly prevalent, occurring in approximately 1% of the population and affecting both men and women equally. The disorder has a typical onset of between 15 and 35 years of age and is characterised by impairments in reality, most commonly hallucinations and delusions. It is a highly complex condition and is often confused with other mental disorders such as bipolar disorder. This new edition will cover new DSM-5 diagnostic
criteria and to reflect new data and include new longitudinal studies on psychiatric and medical co-morbidity, Genetic and environmental factors, new drug therapies, adherence and the role of depots, new advances in psychosocial therapies (CBT,ACT, & cognitive remediation) and includes an updated and expanded appendix.